{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20170228",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "47385",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/208794Orig1s00ltredt.pdf",
              "date": "20170301",
              "type": "Letter"
            },
            {
              "id": "47434",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208794s000lbl.pdf",
              "date": "20170303",
              "type": "Label"
            },
            {
              "id": "47848",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208794Orig1s000TOC.html",
              "date": "20170404",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20201026",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "65044",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208794s001lbl.pdf",
              "date": "20201027",
              "type": "Label"
            },
            {
              "id": "65107",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208794Orig1s001ltr.pdf",
              "date": "20201030",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20220926",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "72160",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/208794Orig1s004ltr.pdf",
              "date": "20220927",
              "type": "Letter"
            },
            {
              "id": "72163",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208794s004lbl.pdf",
              "date": "20220927",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA208794",
      "sponsor_name": "TERSERA",
      "openfda": {
        "application_number": [
          "NDA208794"
        ],
        "brand_name": [
          "XERMELO"
        ],
        "generic_name": [
          "TELOTRISTAT ETHYL"
        ],
        "manufacturer_name": [
          "Lexicon Pharmaceuticals, Inc.",
          "TerSera Therapeutics LLC"
        ],
        "product_ndc": [
          "70183-125",
          "70720-125"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "TELOTRISTAT ETHYL"
        ],
        "rxcui": [
          "1872453",
          "1872458"
        ],
        "spl_id": [
          "4d71b74f-8d8b-4701-ba16-08c7c4d8a7f6",
          "ba59d050-c350-492f-a421-f4b64f6fc60e",
          "e836a23a-0f46-4802-8552-0c82b7e0e1c3"
        ],
        "spl_set_id": [
          "f9108ac3-ca6e-4faf-9d04-953abb64d072",
          "a4ac9d62-887c-4c8f-b04d-a5f31cec7c86",
          "f11c21f8-f725-445e-b38e-1e4c5b05bcc6"
        ],
        "package_ndc": [
          "70183-125-22",
          "70183-125-85",
          "70720-125-22",
          "70720-125-85",
          "70183-125-03",
          "70183-125-21",
          "70183-125-84"
        ],
        "unii": [
          "8G388563M7"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "XERMELO",
          "active_ingredients": [
            {
              "name": "TELOTRISTAT ETIPRATE",
              "strength": "EQ 250MG BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}